Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease
- PMID: 8179300
- DOI: 10.1002/ana.410350507
Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease
Abstract
Glucose metabolism is depressed in the temporal and parietal regions of the cortex in patients with Alzheimer's disease. We measured the concentrations of two glucose transporters, GLUT1 and GLUT3, in six regions of brains from both control subjects and patients with Alzheimer's disease. The concentrations of both transporters were reduced in the cerebral cortex, with larger and highly significant reductions observed for GLUT3, the putative neuronal glucose transporter. The reductions in GLUT3 were greater than the loss of synapses, and should be considered as a potential cause of the deficits in glucose metabolism.
Comment in
-
Glucose transport and phosphorylation: which is rate limiting for brain glucose utilization?Ann Neurol. 1994 May;35(5):511-2. doi: 10.1002/ana.410350503. Ann Neurol. 1994. PMID: 8179296 No abstract available.
Similar articles
-
Functional alterations in Alzheimer's disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone.J Neuropathol Exp Neurol. 1995 Jan;54(1):38-41. J Neuropathol Exp Neurol. 1995. PMID: 7815078
-
Effects of hypoxia-ischemia on GLUT1 and GLUT3 glucose transporters in immature rat brain.J Cereb Blood Flow Metab. 1996 Jan;16(1):77-81. doi: 10.1097/00004647-199601000-00009. J Cereb Blood Flow Metab. 1996. PMID: 8530559
-
Immunolocalization of GLUT1 and GLUT3 glucose transporters in primary cultured neurons and glia.J Neurosci Res. 1995 Nov 1;42(4):459-69. doi: 10.1002/jnr.490420404. J Neurosci Res. 1995. PMID: 8568932
-
Glucose transporters in brain in health and disease.Pflugers Arch. 2020 Sep;472(9):1299-1343. doi: 10.1007/s00424-020-02441-x. Epub 2020 Aug 13. Pflugers Arch. 2020. PMID: 32789766 Free PMC article. Review.
-
Glucose transporter 3 in neuronal glucose metabolism: Health and diseases.Metabolism. 2021 Oct;123:154869. doi: 10.1016/j.metabol.2021.154869. Epub 2021 Aug 21. Metabolism. 2021. PMID: 34425073 Review.
Cited by
-
Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders.J Cereb Blood Flow Metab. 2023 Jan;43(1):26-43. doi: 10.1177/0271678X221135061. Epub 2022 Oct 24. J Cereb Blood Flow Metab. 2023. PMID: 36281012 Free PMC article. Review.
-
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):486-510. doi: 10.1007/s00259-005-1762-7. Eur J Nucl Med Mol Imaging. 2005. PMID: 15747152 Review.
-
Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation.Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12108-13. doi: 10.1073/pnas.96.21.12108. Proc Natl Acad Sci U S A. 1999. PMID: 10518584 Free PMC article.
-
Duodenal-Jejunal Bypass Ameliorates Type 2 Diabetes Mellitus by Activating Insulin Signaling and Improving Glucose Utilization in the Brain.Obes Surg. 2020 Jan;30(1):279-289. doi: 10.1007/s11695-019-04153-3. Obes Surg. 2020. PMID: 31605365
-
Environmental factors in the development and progression of late-onset Alzheimer's disease.Neurosci Bull. 2014 Apr;30(2):253-70. doi: 10.1007/s12264-013-1425-9. Epub 2014 Mar 24. Neurosci Bull. 2014. PMID: 24664867 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous